I found this book very interesting and refreshing. It has added value as a palliative care text because it is written by an oncologist. Michael Owens covers the complete range of issues that the physician may face when caring for a patient with cancer. By definition some of these are only dealt with briefly; however, all are mentioned in a way that is clinically meaningful. Some of the nonphysical problems, for example socioeconomic, are discussed with a strong North American slant but even this area is not without relevance in Europe.
This text could be very useful for the oncologist in training and even thought provoking for the established oncologist. This major new text is a well-presented and comprehensive review of melanoma. This first edition is presented in hardback with over 650 pages of text divided into 14 sections, which are further subdivided into 64 chapters. It has 94 contributors who practice in 14 different countries and therefore represents a truly global overview of current practice. Despite its size, the book is easy for the reader to navigate through due to its simple layout and wellstructured chapters. It also benefits from over 300 colour illustrations, photographs, and line drawings, and many helpful tables and information boxes. The index is extensive making specific information easy to find and all chapters are well referenced.
The 'Textbook of Melanoma' includes sections on the basic biology of the pigment cell system, the aetiology, prevention, and screening of melanoma, and histopathology, classification, staging, and prognosis. It also covers diagnostic methods, the management of primary cutaneous melanoma, regional lymph nodes, and locally recurrent melanoma, as well as the diagnosis and systemic therapy of metastatic disease. There is also a useful chapter on primary melanoma in noncutaneous sites, and a review of current published guidelines.
All chapters include a historical perspective, detailed information regarding current understanding and best practice and where appropriate, challenges to the legitimacy of current practice with possible alternatives. For example, the chapter on staging systems for cutaneous melanoma describes early staging systems used from the 1950s, the application of the TMN staging system to melanoma in the 1960s, and the development of microstaging and use of Clark level and Breslow depth. The 1997 AJCC staging system for cutaneous melanoma is described in detail, and then critically analysed with proposed changes. *Correspondence: Dr M Gore; E-mail: martin.gore@rmh.nthames.nhs.uk www.bjcancer.com
